# Zonisamide Versus Propranolol in Migraine

> **NCT06361446** · PHASE3 · UNKNOWN · sponsor: **Kafrelsheikh University** · enrollment: 600 (estimated)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** Zonisamide 50 MG
- **DRUG:** Propranolol

## Key facts

- **NCT ID:** NCT06361446
- **Lead sponsor:** Kafrelsheikh University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-29
- **Primary completion:** 2025-03-30
- **Final completion:** 2025-04-20
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2024-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06361446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06361446, "Zonisamide Versus Propranolol in Migraine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06361446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*